Profluent Bio
Description
🖼️ Tool / Company Name:
Profluent Bio
🔖 Tool Category:
AI-powered protein design / biotech platform; falls under the category of autonomous development tools that transform deep generative biology models into novel functional proteins.
✏️ What does this tool offer?
Profluent Bio describes itself as an “AI-first protein design company” that uses deep generative models to design and validate novel functional proteins.
They combine machine learning and biology to “author new biology … creating solutions that transform medicine, agriculture, and beyond.”
One of their initiatives is “OpenCRISPR”, described as the world’s first AI-designed gene-editor which they open-sourced for ethical research and commercial use.
⭐ What does the tool actually deliver based on user experience?
• It develops deep generative protein models to propose novel protein sequences and scaffolds.
• It has announced a publicly available gene editing system (OpenCRISPR-1) that was AI-designed from scratch.
• It aims to accelerate discovery of new therapeutic proteins (and possibly enzymes for other industries).
• The company positions itself in a B2B / biotech partner context (rather than a consumer app).
🤖 Does it include automation?
Yes — automation is central:
• Uses generative AI (deep learning) to design novel proteins automatically.
• Validates and iterates protein candidates (presumably via automated screening, though specifics are less public).
• Publishes open-source gene editors for broader use, demonstrating automated design to deployment.
💰 Pricing Model:
Not publicly described in typical “freemium/sub-subscription” form. As a biotech platform, it likely follows enterprise / partnership / licensing model.
🆓 Free Plan Details:
• There is no typical “free plan” for end-users.
• However, the open-source gene editor initiative (OpenCRISPR-1) provides a free license for research / commercial use under certain conditions.
💳 Paid Plan Details:
• Specific pricing/licensing terms are not publicly disclosed.
• The platform is likely structured via collaborations, licensing deals, and enterprise contracts rather than standard SaaS tiers.
🧭 Access Method:
• Company website:
• OpenCRISPR-1 license available for research/commercial uses via Profluent Bio.
🔗 Experience Links:
https://www.profluent.bio